SEARCH

SEARCH BY CITATION

References

  • Adell A. and Artigas F. (1999) Regulation of the release of 5-hydroxytryptamine in the median raphe nucleus of the rat by catecholaminergic afferents. Eur. J. Neurosci. 11, 23052311.
  • Adell A., Casanovas J. M. and Artigas F. (1997) Comparative study in the rat of the actions of different types of stress on the release of 5-HT in raphe nuclei and forebrain areas. Neuropharmacology 36, 735741.
  • American Psychiatric Association. (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th edn, pp. 393444. American Psychiatric Association, Washington, DC.
  • Artigas F., Romero L., De Montigny C. and Blier P. (1996) Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists. Trends Neurosci. 19, 378383.
  • Balant-Gorgia A. E., Gex-Fabry M. and Balant L. P. (1991) Clinical pharmacokinetics of clomipramine. Clin. Pharmacokinet. 20, 447462.
  • Baraban J. M. and Aghajanian G. K. (1980) Suppression of firing activity of 5-HT neurons in the dorsal raphe by α-adrenoceptor antagonists. Neuropharmacology 19, 355363.
  • Bel N. and Artigas F. (1996) In vivo effects of the simultaneous blockade of serotonin and norepinephrine transporters on serotonergic function: microdialysis studies. J. Pharmacol. Exp. Ther. 278, 10641072.
  • Bengel D., Johren O., Andrews A. M., Heils A., Mossner R., Sanvitto G. L., Saavedra J. M., Lesch K. P. and Murphy D. L. (1997) Cellular localization and expression of the serotonin transporter in mouse brain. Brain Res. 778, 338345.
  • Blier P. and De Montigny C. (1994) Current advances and trends in the treatment of depression. Trends Pharmacol. Sci. 15, 220226.
  • Den Boer J. A., Westenberg H. G., Kamerbeek W. D., Verhoeven W. M. and Kahn R. S. (1987) Effect of serotonin uptake inhibitors in anxiety disorders; a double-blind comparison of clomipramine and fluvoxamine. Int. Clin. Psychopharmacol. 2, 2132.
  • Carboni E. and Di Chiara G. (1989) Serotonin release estimated by transcortical dialysis in freely-moving rats. Neuroscience 32, 637645.
  • Casanovas J. M. and Artigas F. (1996) Differential effects of ipsapirone on 5-hydroxytryptamine release in the dorsal and median raphe neuronal pathways. J. Neurochem. 67, 19451952.
  • Charnay Y., Steimer T., Huguenin C. and Driscoll P. (1995) [3H] Paroxetine binding sites: brain regional differences between two psychogenetically selected lines of rats. Neurosci. Res. Comm. 16, 2935.
  • Corda M. G., Lecca D., Piras G., Di Chiara G. and Giorgi O. (1997a) Biochemical parameters of dopaminergic and GABAergic neurotransmission in the CNS of Roman high-avoidance and Roman low-avoidance rats. Behav. Genet. 27, 527536.
  • Corda M. G., Lecca D., Piras G., Di Chiara G. and Giorgi O. (1997b) Tail-pinch and pentylenetetrazol increase the release of serotonin in the cerebral cortex of Roman high-avoidance, but not low avoidance rats. Neurosci. Meeting Abstract 23, 1850.
  • Crowe R. R. (1999) Molecular genetics of anxiety disorders. In: Neurobiology of Mental Illness (CharneyD. S., NestlerE. J. and BunneyB. S., eds), pp. 451462. Oxford University Press, New York.
  • De Vry J. (1995) 5-HT1A receptor agonists: recent developments and controversial issues. Psychopharmacology 121, 126.
  • Driscoll P., Dedek J., Martin J. R. and Zivkovic B. (1983) Two-way avoidance and acute shock stress induced alterations of regional noradrenergic, dopaminergic and serotonergic activity in Roman high- and low-avoidance rats. Life Sci. 24, 17191725.
  • Driscoll P., Escorihuela R. M., Fernández-Teruel A., Giorgi O., Schwegler H., Steimer T., Wiersma A., Corda M. G., Flint J., Koolhaas J. M., Langhans W., Schulz P. E., Siegel J. and Tobeña A. (1998) Genetic selection and differential stress responses: The Roman lines/strains of rats. Ann. N.Y. Acad. Sci. 851, 501510.
  • Fernández-Teruel A., Escorihuela R. M., Gray J. A., Aguilar R., Gil L., Gimenez-Llort L., Tobeña A., Bhomra A., Nicod A., Mott R., Driscoll P., Dawson G. R. and Flint J. (2002) A quantitative trait locus influencing anxiety in the laboratory rat. Genome Res. 12, 618626.
  • Giorgi O., Corda M. G., Carboni G., Frau V. and Di Chiara G. (1997) Effects of cocaine and morphine in rats from two psychogenetically selected lines: a behavioral and brain dialysis study. Behav. Genet. 27, 537546.
  • Goddard A. W., Coplan J. D., Gorman J. M. and Charney D. S. (1999) Principles of the pharmacotherapy of anxiety disorders. In: Neurobiology of Mental Illness (CharneyD. S., NestlerE. J. and BunneyB. S., eds), pp. 548563. Oxford University Press, New York.
  • Griebel G., Moreau J. L., Jenck F., Misslin R. and Martin J. R. (1994) Acute and chronic treatment with 5-HT reuptake inhibitors differentially modulate emotional responses in anxiety models in rodents. Psychopharmacology 113, 463470.
  • Halliday G., Harding A. and Paxinos G. (1995) Serotonin and tachykinin systems. In: The Rat Nervous System, 2nd edn. (PaxinosG., ed.), pp. 929974. Academic Press, San Diego.
  • Handley S. L. (1995) 5-Hydroxytryptamine pathways in anxiety and its treatment. Pharmacol. Ther. 66, 103148.
  • Hrdina P. D., Foy B., Hepner A. and Summers R. J. (1990) Antidepressant binding sites in brain: autoradiographic comparison of [3H] paroxetine and [3H] imipramine localization and relationship to serotonin transporter. J. Pharmacol. Exp. Ther. 252, 410418.
  • Invernizzi R., Velasco C., Bramante M., Longo A. and Samanin R. (1997) Effect of 5-HT1A receptor antagonists on citalopram-induced increase in extracellular serotonin in the frontal cortex, striatum and dorsal hippocampus. Neuropharmacology 36, 467473.
  • Kaplan H. I., Sadock B. J. and Grebb J. A. (1994) Synopsis of Psychiatry, 7th edn, pp. 516572. Williams & Wilkins, Baltimore.
  • Kindler S., Dolberg O. T., Cohen H., Hirschmann S. and Kotler M. (1997) The treatment of co-morbid premature ejaculation and panic disorder with fluoxetine. Clin. Neuropharmacol. 20, 466471.
  • Kulikov A., Castanon N., Mormède P. and Chaouloff F. (1995) Cerebral tryptophan hydroxylase activity, and 5-HT1A receptor, 5-HT2A receptor, and 5-HT transporter binding in grouped and isolated Roman RHA and RLA rats: relationships with behaviours in two models of anxiety. Psychopharmacology 121, 385395.
  • Li Q., Muma N. A. and Van De Kar L. D. (1996) Chronic fluoxetine induces a gradual desensitization of 5-HT1A receptors: reductions in hypothalamic and midbrain Gi and Go proteins and in neuroendocrine responses to a 5-HT1A agonist. J. Pharmacol. Exp. Ther. 279, 10351042.
  • Mancini C. and Ameringen M. V. (1996) Paroxetine in social phobia. J. Clin. Psychiatry 57, 519522.
  • Mateo Y., Pineda J. and Meana J. J. (1998) Somatodendritic alpha2-adrenoceptors in the locus coeruleus are involved in the in vivo modulation of cortical noradrenaline release by the antidepressant desipramine. J. Neurochem. 71, 790798.
  • Paxinos G. and Watson C. (1998) The Rat Brain in Stereotaxic Coordinates, 4th edn. Academic Press, San Diego.
  • Qian Y., Melikian H. E., Rye D. B., Levey A. I. and Blakely R. D. (1995) Identification and characterization of antidepressant-sensitive serotonin transporter proteins using site-specific antibodies. J. Neurosci. 15, 12611274.
  • Sanders A. R., Sevilla D., Detera-Wadleigh S. D. and Gershon E. S. (1999) Molecular genetics of mood disorders. In: Neurobiology of Mental Illness (CharneyD. S., NestlerE. J. and BunneyB. S., eds), pp. 299316. Oxford University Press, New York.
  • Steimer T., La Fleur S. and Schulz P. (1997) Neuroendocrine correlates of emotional reactivity and coping in male rats from the Roman high (RHA/Verh)- and low (RLA/Verh)-avoidance lines. Behav. Genet. 27, 503512.
  • Sur C., Betz H. and Schloss P. (1996) Immunocytochemical detection of the serotonin transporter in rat brain. Neuroscience 73, 217231.
  • Willner P. (1991) Animal models of depression. In: Behavioural Models in Psychopharmacology: Theoretical, Industrial and Clinical Perspectives. (Willner, P., ed.), pp. 89174. Cambridge University Press, Cambridge.
  • Zhang Y., Raap D. K., Garcia F., Serres F., Ma Q., Battaglia G. and Van de Kar L. D. (2000) Long-term fluoxetine produces behavioral anxiolytic effects without inhibiting neuroendocrine responses to conditioned stress in rats. Brain Res. 855, 5866.